Julie A. Fields

ORCID: 0000-0002-1282-9866
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dementia and Cognitive Impairment Research
  • Parkinson's Disease Mechanisms and Treatments
  • Alzheimer's disease research and treatments
  • Amyotrophic Lateral Sclerosis Research
  • Neurological disorders and treatments
  • Advanced Neuroimaging Techniques and Applications
  • Neurobiology of Language and Bilingualism
  • Genetic Neurodegenerative Diseases
  • Ginkgo biloba and Cashew Applications
  • Neurological Disease Mechanisms and Treatments
  • Health Systems, Economic Evaluations, Quality of Life
  • Menopause: Health Impacts and Treatments
  • Advanced MRI Techniques and Applications
  • Functional Brain Connectivity Studies
  • Transcranial Magnetic Stimulation Studies
  • Folate and B Vitamins Research
  • Neurological diseases and metabolism
  • Glycogen Storage Diseases and Myoclonus
  • Frailty in Older Adults
  • Attention Deficit Hyperactivity Disorder
  • Cerebrovascular and Carotid Artery Diseases
  • Cognitive Functions and Memory
  • Pregnancy and preeclampsia studies
  • Prion Diseases and Protein Misfolding
  • Epilepsy research and treatment

WinnMed
2016-2025

Mayo Clinic
2016-2025

Mayo Clinic in Arizona
2015-2024

VIB-UAntwerp Center for Molecular Neurology
2024

University of Antwerp
2024

University of California, Los Angeles
2024

Centre National de la Recherche Scientifique
2020-2024

Mayo Clinic in Florida
2012-2024

Banner Sun Health Research Institute
2024

University of Arizona
2024

Objective: To determine if functional connectivity of the hippocampus is reduced in patients with Alzheimer disease.Design: Functional magnetic resonance imaging was used to investigate coherence signal between and all other regions brain.Participants: Eight probable disease 8 healthy volunteers.Results: Control subjects showed hippocampal diffuse cortical, subcortical, cerebellar sites, while demonstrated markedly connectivity, including an absence frontal lobes. Conclusion:These findings...

10.1001/archneur.64.10.1482 article EN Archives of Neurology 2007-10-01

Numerous kindreds with familial frontotemporal dementia and/or amyotrophic lateral sclerosis have been linked to chromosome 9, and an expansion of the GGGGCC hexanucleotide repeat in non-coding region 9 open reading frame 72 has recently identified as pathogenic mechanism. We describe key characteristics probands their affected relatives who evaluated at Mayo Clinic Rochester or Florida whom were found. Forty-three 10 DNA available (total 53 subjects) shown carry expansion. Thirty-six (84%)...

10.1093/brain/aws004 article EN cc-by-nc Brain 2012-02-24

Patients with probable dementia Lewy bodies (DLB) often have Alzheimer's disease (AD)-related pathology. Our objective was to determine the pattern of positron emission tomography (PET) tau tracer AV-1451 uptake in patients DLB, compared AD, and its relationship β-amyloid deposition on PET.Consecutive clinically DLB (n = 19) from Mayo Clinic Disease Research Center underwent magnetic resonance imaging, AV-1451, Pittsburgh compound-B (PiB) PET examinations. Age- sex-matched groups AD normal...

10.1002/ana.24825 article EN cc-by-nc Annals of Neurology 2016-11-19

Large phenotypically diverse research cohorts with both amyloid and tau PET have only recently come into existence. Our objective was to determine relationships between the bivariate distribution of amyloid-β on established clinical syndromes that are relevant cognitive ageing dementia. All individuals in this study were enrolled Mayo Clinic Study Aging, a longitudinal population-based ageing, or Alzheimer Disease Research Center, recruited from practice. We studied 1343 participants who had...

10.1093/brain/awz268 article EN cc-by-nc Brain 2019-08-28
Adam M. Staffaroni Melanie Quintana Barbara Wendelberger Hilary W. Heuer Lucy L. Russell and 95 more Yann Cobigo Amy Wolf Sheng‐Yang M. Goh Leonard Petrucelli Tania F. Gendron Carolin Heller Annie L Clark Jack C. Taylor Amy B. Wise Elise Ong Leah K. Forsberg Danielle Brushaber Julio C. Rojas Lawren VandeVrede Peter A. Ljubenkov Joel H. Kramer Kaitlin B. Casaletto Brian S. Appleby Yvette Bordelon Hugo Botha Bradford C. Dickerson Kimiko Domoto‐Reilly Julie A. Fields Tatiana Foroud Ralitza H. Gavrilova Daniel H. Geschwind Nupur Ghoshal Jill Goldman Jonathon Graff-Radford Neill R. Graff‐Radford Murray Grossman Matthew Hall Ging‐Yuek Robin Hsiung Edward D. Huey David J. Irwin David T. Jones Kejal Kantarci Daniel Kaufer David S. Knopman Walter K. Kremers Argentina Lario Lago Maria I. Lapid Irene Litvan Diane Lucente Ian R. Mackenzie Mario F. Mendez Carly T. Mester Bruce L. Miller Chiadi U. Onyike Rosa Rademakers Vijay K. Ramanan Eliana Marisa Ramos Meghana Rao Katya Rascovsky Katherine P. Rankin Erik D. Roberson Rodolfo Savica Maria Carmela Tartaglia Sandra Weıntraub Bonnie Wong David M. Cash Arabella Bouzigues Imogen J. Swift Georgia Peakman Martina Bocchetta Emily Todd Rhian S. Convery James B. Rowe Barbara Borroni Daniela Galimberti Pietro Tiraboschi Mario Masellis Elizabeth Finger John C. van Swieten Harro Seelaar Lize C. Jiskoot Sandro Sorbi Christopher Butler Caroline Graff Alexander Gerhard Tobias Langheinrich Robert Laforce Raquel Sánchez‐Valle Alexandre de Mendonça Fermín Moreno Matthis Synofzik Rik Vandenberghe Simon Ducharme Isabelle Le Ber Johannes Levin Adrian Danek Markus Otto Florence Pasquier Isabel Santana John Kornak

10.1038/s41591-022-01942-9 article EN Nature Medicine 2022-09-22

Abstract BACKGROUND We compared the ability of several plasma biomarkers versus amyloid positron emission tomography (PET) to predict rates memory decline among cognitively unimpaired individuals. METHODS studied 645 Mayo Clinic Study Aging participants. Predictor variables were age, sex, education, apolipoprotein E ( APOE ) ε 4 genotype, PET, and beta (Aβ)42/40, phosphorylated tau (p‐tau)181, neurofilament light (NfL), glial fibrillary acidic protein (GFAP), p‐tau217. The outcome was a...

10.1002/alz.13651 article EN cc-by-nc-nd Alzheimer s & Dementia 2024-01-24

OBJECTIVES: To determine the effect of a primary care–based collaborative care program for depression on suicidal ideation in older adults. DESIGN: Randomized, controlled trial. SETTING: Eighteen diverse clinics. PARTICIPANTS: One thousand eight hundred one adults aged 60 and with major or dysthymia. INTERVENTION: Participants randomized to had access manager who supported antidepressant medication management prescribed by their physician offered course Problem Solving Treatment Primary Care...

10.1111/j.1532-5415.2006.00882.x article EN Journal of the American Geriatrics Society 2006-09-08

BackgroundHypertension is a risk factor for cerebrovascular disease and cognitive impairment. Women with hypertensive episodes during pregnancy report variable neurocognitive changes within the first decade following affected pregnancy. However, long-term follow-up of these women into their postmenopausal years has not been conducted.ObjectiveThe aim this study was to examine whether history preeclampsia were at increased decline 35-40 after pregnancy.Study DesignWomen identified recruited...

10.1016/j.ajog.2017.03.008 article EN cc-by-nc-nd American Journal of Obstetrics and Gynecology 2017-03-18

Abstract Introduction We created global rating scoring rules for the CDR ® plus NACC FTLD to detect and track early frontotemporal lobar degeneration (FTLD) conduct clinical trials in FTLD. Methods The was applied 970 sporadic familial participants from baseline visit of Advancing Research Treatment Frontotemporal Lobar Degeneration (ARTFL)/Longitudinal Evaluation Familial Dementia Subjects (LEFFTDS). Each eight domains equally weighed determining score. An interrater reliability study...

10.1002/alz.12033 article EN Alzheimer s & Dementia 2020-01-01

It remains controversial whether hormone therapy in recently postmenopausal women modifies the risk of Alzheimer's disease (AD).To investigate effects on amyloid-β deposition women.Participants within 5-36 months past menopause Kronos Early Estrogen Prevention Study, a randomized, double blinded placebo-controlled clinical trial, were randomized to: 1) 0.45 mg/day oral conjugated equine estrogens (CEE); 2) 50μg/day transdermal 17β-estradiol; or 3) placebo pills and patch for four years. Oral...

10.3233/jad-160258 article EN Journal of Alzheimer s Disease 2016-07-13

In a multicenter cohort of probable dementia with Lewy bodies (DLB), we tested the hypothesis that β-amyloid and tau biomarker positivity increases age, which is modified by APOE genotype sex, there are isolated synergistic associations clinical phenotype.We included 417 patients DLB (age 45-93 years, 31% women). Positivity on (A+) (T+) biomarkers was determined CSF β-amyloid1-42 phosphorylated in European Pittsburgh compound B AV-1451 PET Mayo Clinic cohort. Patients were stratified into 4...

10.1212/wnl.0000000000010943 article EN Neurology 2020-09-29

At present, no research criteria exist for the diagnosis of prodromal behavioural variant frontotemporal dementia (bvFTD), though early detection is high importance. Thus, we sought to develop and validate a proposed set bvFTD, termed 'mild and/or cognitive impairment in bvFTD' (MBCI-FTD). Participants included 72 participants deemed have bvFTD; this comprised 55 carriers pathogenic mutation known cause lobar degeneration, 17 individuals with autopsy-confirmed degeneration. All had mild...

10.1093/brain/awab365 article EN cc-by-nc Brain 2021-09-30

Frontotemporal dementia (FTD) therapy development is hamstrung by a lack of susceptibility, diagnostic, and prognostic biomarkers. Blood neurofilament light (NfL) shows promise as biomarker, but studies have largely focused only on core FTD syndromes, often grouping patients with different diagnoses. To expedite the clinical translation NfL, we avail ARTFL LEFFTDS Longitudinal Lobar Degeneration (ALLFTD) study resources conduct comprehensive investigation plasma NfL across syndromes in...

10.1016/j.xcrm.2022.100607 article EN cc-by-nc-nd Cell Reports Medicine 2022-04-01

Rapid eye movement (REM) sleep behavior disorder (RBD) is widely considered a prodromal synucleinopathy, as most with RBD develop overt synucleinopathy within ~10 years. Accordingly, offers an opportunity to test potential treatments at the earliest stages of synucleinopathy. The North American Prodromal Synucleinopathy (NAPS) Consortium has created multisite participant, primarily clinic-based cohort better understand characteristics diagnosis, and in future work, identify predictors...

10.1002/acn3.51738 article EN cc-by Annals of Clinical and Translational Neurology 2023-02-08

Abstract INTRODUCTION Patients with dementia Lewy bodies (DLB) may have Alzheimers disease (AD) pathology that can be detected by plasma biomarkers. Our objective was to evaluate biomarkers of AD and their association positron emission tomography (PET) amyloid tau deposition in the continuum DLB, starting from prodromal stages disease. METHODS The cohort included patients isolated rapid eye movement (REM) sleep behavior disorder (iRBD), mild cognitive impairment (MCI‐LB), or a concurrent...

10.1002/alz.13653 article EN cc-by Alzheimer s & Dementia 2024-02-08
Adam M. Staffaroni Annie L Clark Jack C. Taylor Hilary W. Heuer Mark Sanderson‐Cimino and 95 more Amy B. Wise Sreya Dhanam Yann Cobigo Amy Wolf Masood Manoochehri Leah K. Forsberg Carly T. Mester Katherine P. Rankin Brian S. Appleby Ece Bayram Andrea Bozoki David Clark R. Ryan Darby Kimiko Domoto‐Reilly Julie A. Fields Douglas Galasko Daniel H. Geschwind Nupur Ghoshal Neill R. Graff‐Radford Murray Grossman Ging‐Yuek Robin Hsiung Edward D. Huey David T. Jones Maria I. Lapid Irene Litvan Joseph C. Masdeu Lauren Massimo Mario F. Mendez Toji Miyagawa Belén Pascual Peter Pressman Vijay K. Ramanan Eliana Marisa Ramos Katya Rascovsky Erik D. Roberson Maria Carmela Tartaglia Bonnie Wong Bruce L. Miller John Kornak Walter K. Kremers Jason Hassenstab Joel H. Kramer Bradley F. Boeve Howard J. Rosen Adam L. Boxer Liana G. Apostolova Brian S. Appleby Sami J. Barmada Ece Bayram Bradley F. Boeve Hugo Botha Adam L. Boxer Andrea Bozoki Danielle Brushaber Annie L Clark Yann Cobigo R. Ryan Darby Gregory S. Day Sreya Dhanam Bradford Dickerson Dennis W. Dickson Kimiko Domoto‐Reilly Fanny M. Elahi Kelley Faber Anne M. Fagan Julie A. Fields Jamie Fong Tatiana M. Foroud Leah K. Forsberg Douglas Galasko Ralitza H. Gavrilova Tania F. Gendron Daniel H. Geschwind Nupur Ghoshal Jill Goldman Neill R. Graff‐Radford Jonathan Graff‐Radford Ian Grant Murray Grossman Matthew Hall Chadwick M. Hales Hilary W. Heuer Lawrence S. Honig Ging‐Yuek Robin Hsiung Eric J. Huang Edward D. Huey David J. Irwin Noah R. Johnson David T. Jones Kejal Kantarci David S. Knopman Tyler Kolander John Kornak Walter K. Kremers Justin Kwan

Importance Frontotemporal lobar degeneration (FTLD) is relatively rare, behavioral and motor symptoms increase travel burden, standard neuropsychological tests are not sensitive to early-stage disease. Remote smartphone-based cognitive assessments could mitigate these barriers trial recruitment success, but no such tools validated for FTLD. Objective To evaluate the reliability validity of measures remote FTLD evaluations. Design, Setting, Participants In this cohort study conducted from...

10.1001/jamanetworkopen.2024.4266 article EN cc-by-nc-nd JAMA Network Open 2024-04-01

Abstract Predominant limbic degeneration has been associated with various underlying aetiologies and an older age, predominant impairment of episodic memory slow clinical progression. However, the neurological syndrome is not defined. This endeavour critical to distinguish such a from those originating neocortical degeneration, which may differ in aetiology, disease course therapeutic needs. We propose set criteria for limbic-predominant amnestic neurodegenerative that highly age-related...

10.1093/braincomms/fcae183 article EN cc-by Brain Communications 2024-01-01

Background Mayo Test Drive (MTD): Development through Rapid Iteration, Validation and Expansion, is a web-based remote cognitive assessment platform for self-administered neuropsychological measures with previously demonstrated validity reliability. We examined the usability of MTD hypothesized that completion rates would be greater than 90%. explored whether participation differed by status demographic factors.

10.1080/13803395.2025.2464633 article EN cc-by-nc-nd Journal of Clinical and Experimental Neuropsychology 2025-02-20

Previous research suggests that lexical and semantic verbal fluency are differentially sensitive to the effects of cortical subcortical dementias, but little is known about action performance in dementias. The present study compared lexical, semantic, groups patients with Parkinson's disease (PD) without dementia an elderly control group. Findings revealed interaction between type subject Although demented PD (PDD) group performed significantly more poorly than their non-demented...

10.1076/jcen.21.4.435.885 article EN Journal of Clinical and Experimental Neuropsychology 1999-08-01

Few studies have been published regarding the neuropsychological characteristics of patients with essential tremor (ET), but preliminary findings suggest that mild attentional and executive dysfunction accompany disorder. A consecutive series 101 ET referred for thalamotomy and/or thalamic deep brain stimulation candidacy work-up also underwent evaluation. Average test scores were calculated, along proportions subjects whose fell within or more than one SD above below mean (using...

10.1046/j.1468-1331.2002.00341.x article EN European Journal of Neurology 2002-03-01
Coming Soon ...